<em>Astragalus</em> polysaccharide alleviates asthma by modulating gut microbiota and serum metabolomics

Zhang,Jie; Guan,Ming; Wu,Suling; Sheng,Wenbin

doi:10.3892/br.2024.1890

Astragalus polysaccharide alleviates asthma by modulating gut microbiota and serum metabolomics

Authors:
- Jie Zhang
- Ming Guan
- Suling Wu
- Wenbin Sheng
View Affiliations

Affiliations: Department of Pediatrics, Hangzhou Children's Hospital, Hangzhou, Zhejiang 310014, P.R. China, Department of Otolaryngology, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou, Zhejiang 310006, P.R. China, Department of Pediatrics, Hangzhou Children's Hospital, Hangzhou, Zhejiang 310014, P.R. China
Published online on: November 13, 2024 https://doi.org/10.3892/br.2024.1890
Article Number: 12
Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to examine the effects of Astragalus polysaccharide (APS) on gut microbiota and serum metabolites in asthmatic mice. For this purpose, a total of 36 BALB/c female mice were selected and randomly classified into the following groups: i) The normal control group sensitized with phosphate‑buffered saline; ii) the asthma group sensitized and challenged with ovalbumin (OVA); iii) the OVA + APS (2.5 g/kg) treatment group; iv) the OVA + APS (5.0 g/kg) treatment group; v) the OVA + APS (10 g/kg) treatment group; and vi) the OVA + dexamethasone (2 mg/kg) treatment group, with 6 mice in each group. OVA was used to establish the mouse model of asthma. In the APS group, the asthmatic mice were intragastrically administered APS at various doses at 1 h prior to each OVA stimulation. The airway hyperreactivity (AHR) was measured, and hematoxylin and eosin staining was employed to evaluate pulmonary inflammatory infiltration. In addition, 16S rRNA sequencing and ultra‑performance liquid chromatography‑tandem mass spectrometry were used to detect the changes in the mouse gut microbiota and serum metabolites. The results revealed that compared with the asthma model group, APS improved airway inflammation and eosinophil infiltration in asthmatic mice. In asthmatic mice, the gut microbial imbalance mainly manifested as a low abundance of Bacteroidetes and a high abundance of Firmicutes, yielding an increased F/B ratio. In the high‑dose APS group, the abundance of Firmicutes was reduced, and the abundance of Bacteroidetes was increased, which thereby decreased the F/B ratio and corrected the gut microbial imbalance. Through blood metabolomics, 145 and 105 significantly differential metabolites were detected in the medium‑ and high‑dose APS groups, respectively. Moreover, Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis demonstrated that the metabolic pathways in the medium‑dose APS group included the biosynthesis of unsaturated fatty acids and the biosynthesis of arginine. On the other hand, the metabolic pathways enriched in high‑dose APS group were the biosynthesis of unsaturated fatty acids, and pyrimidine metabolism. On the whole, the present study demonstrates that APS may regulate the gut microbiota and the metabolites to improve airway inflammation and AHR in asthmatic mice.

View Figures

View References

1	Sun J, Bai S, Zhao J, Li D, Ma X, Ma L and Su X: Mapping knowledge structure and research of the biologic treatment of asthma: A bibliometric study. Front Immunol. 14(1034755)2023.PubMed/NCBI View Article : Google Scholar
2	Agusti A, Fabbri L, Lahousse L, Singh D and Papi A: Single inhaler triple therapy (SITT) in asthma: Systematic review and practice implications. Allergy. 77:1105–1113. 2022.PubMed/NCBI View Article : Google Scholar
3	Chan HL and Ng T: Traditional Chinese Medicine (TCM) and allergic diseases. Curr Allergy Asthma Rep. 20(67)2020.PubMed/NCBI View Article : Google Scholar
4	Yang N and Shang YX: Epigallocatechin gallate ameliorates airway inflammation by regulating Treg/Th17 imbalance in an asthmatic mouse model. Int Immunopharmacol. 72:422–428. 2019.PubMed/NCBI View Article : Google Scholar
5	Zheng Y, Ren W, Zhang L, Zhang Y, Liu D and Liu Y: A review of the pharmacological action of Astragalus polysaccharide. Front Pharmacol. 11(349)2020.PubMed/NCBI View Article : Google Scholar
6	Zhao X, Hu M, Zhou H, Yang Y, Shen S, You Y and Xue Z: The role of gut microbiome in the complex relationship between respiratory tract infection and asthma. Front Microbiol. 14(1219942)2023.PubMed/NCBI View Article : Google Scholar
7	Chen J, Wang A and Wang Q: Dysbiosis of the gut microbiome is a risk factor for osteoarthritis in older female adults: A case control study. BMC bioinformatics. 22(299)2021.PubMed/NCBI View Article : Google Scholar
8	Zhang D, Li S, Wang N, Tan HY, Zhang Z and Feng Y: The Cross-Talk Between Gut microbiota and lungs in common lung diseases. Front Microbiol. 11(301)2020.PubMed/NCBI View Article : Google Scholar
9	Hansen AW and Venkatachalam KV: Sulfur-Element containing metabolic pathways in human health and crosstalk with the microbiome. Biochem Biophys Rep. 35(101529)2023.PubMed/NCBI View Article : Google Scholar
10	Brown HN, Barber T, Renshaw D, Farnaud S, Oduro-Donkor D and Turner MC: Associations between the gut microbiome and metabolic, inflammatory, and appetitive effects of sleeve gastrectomy. Obes Rev. 24(e13600)2023.PubMed/NCBI View Article : Google Scholar
11	Arrieta MC, Stiemsma LT, Dimitriu PA, Thorson L, Russell S, Yurist-Doutsch S, Kuzeljevic B, Gold MJ, Britton HM, Lefebvre DL, et al: Early infancy microbial and metabolic alterations affect risk of childhood asthma. Sci Transl Med. 7(307ra152)2015.PubMed/NCBI View Article : Google Scholar
12	Li R, Guo Q, Zhao J, Kang W, Lu R, Long Z, Huang L, Chen Y, Zhao A, Wu J, et al: Assessing causal relationships between gut microbiota and asthma: evidence from two sample Mendelian randomization analysis. Front Immunol. 14(1148684)2023.PubMed/NCBI View Article : Google Scholar
13	Luo X, Pan Z, Luo S, Liu Q, Huang S, Yang G, Nong F, Fu Y, Deng X and Zhou L: Effects of ceftriaxone-induced intestinal dysbacteriosis on regulatory T cells validated by anaphylactic mice. Int Immunopharmacol. 60:221–227. 2018.PubMed/NCBI View Article : Google Scholar
14	Loo EX, Llanora GV, Lu Q, Aw MM, Lee BW and Shek LP: Supplementation with probiotics in the first 6 months of life did not protect against eczema and allergy in at-risk Asian infants: a 5-year follow-up. Int Arch Allergy Immunol. 163:25–28. 2014.PubMed/NCBI View Article : Google Scholar
15	Wang F, Wu F, Chen H and Tang B: The effect of probiotics in the prevention of atopic dermatitis in children: A systematic review and meta-analysis. Transl Pediatr. 12:731–748. 2023.PubMed/NCBI View Article : Google Scholar
16	Cavalcanti RFP, Gadelha FAAF, Paiva Ferreira LKD, Paiva Ferreira LAM, Chaves Júnior JV, de Araújo Batista RS, Melo TBL, de Souza FS, Alves AF, Maria Batista L and Piuvezam MR: Limosilactobacillus fermentum modulates the gut-airway axis by improving the immune response through FOXP3 activation on combined allergic rhinitis and asthma syndrome (CARAS). Immunobiology. 228(152721)2023.PubMed/NCBI View Article : Google Scholar
17	Dou M, Chu Y, Zhou X, Wang M, Li X, Ma R, Fan Z, Zhao X, Wang W, Li S, et al: Matrine mediated immune protection in MS by regulating gut microbiota and production of SCFAs. Mol Neurobiol. 61:74–90. 2024.PubMed/NCBI View Article : Google Scholar
18	Hou Q, Huang J, Zhao L, Pan X, Liao C, Jiang Q, Lei J, Guo F, Cui J, Guo Y and Zhang B: Dietary genistein increases microbiota-derived short chain fatty acid levels, modulates homeostasis of the aging gut, and extends healthspan and lifespan. Pharmacol Res. 188(106676)2023.PubMed/NCBI View Article : Google Scholar
19	Tweeddale H, Notley-McRobb L and Ferenci T: Assessing the effect of reactive oxygen species on Escherichia coli using a metabolome approach. Redox Rep. 4:237–241. 1999.PubMed/NCBI View Article : Google Scholar
20	Shah SH, Kraus WE and Newgard CB: Metabolomic profiling for the identification of novel biomarkers and mechanisms related to common cardiovascular diseases: Form and function. Circulation. 126:1110–1120. 2012.PubMed/NCBI View Article : Google Scholar
21	Robinson O and Lau CE: How do metabolic processes age: Evidence from human metabolomic studies. Curr Opin Chem Biol. 76(102360)2023.PubMed/NCBI View Article : Google Scholar
22	Yao Y, Wang X, Guan J, Xie C, Zhang H, Yang J, Luo Y, Chen L, Zhao M, Huo B, et al: Metabolomic differentiation of benign vs malignant pulmonary nodules with high specificity via high-resolution mass spectrometry analysis of patient sera. Nat Commun. 14(2339)2023.PubMed/NCBI View Article : Google Scholar
23	Bjerrum JT, Nielsen OH, Wang YL and Olsen J: Technology insight: metabonomics in gastroenterology-basic principles and potential clinical applications. Nat Clin Pract Gastroenterol Hepatol. 5:332–343. 2008.PubMed/NCBI View Article : Google Scholar
24	Xu J, Zhang Q, Li Z, Gao Y, Pang Z, Wu Y, Li G, Lu D, Zhang L and Li D: Astragalus polysaccharides attenuate ovalbumin-induced allergic rhinitis in rats by inhibiting NLRP3 inflammasome activation and NOD2-Mediated NF-κB activation. J Med Food. 24:1–9. 2021.PubMed/NCBI View Article : Google Scholar
25	He X, Liu L, Luo X, Zhu J, Yang H, Wang J, Chen L and Zhong L: Astragalus polysaccharide relieves inflammatory responses in guinea pigs with allergic rhinitis via ameliorating NF-kB-Mediated Treg/Th17 Imbalance. Am J Rhinol Allergy. 36:638–648. 2022.PubMed/NCBI View Article : Google Scholar